From: The “hidden” epidemic: a snapshot of Moroccan intravenous drug users
Country | Genotype (%) | Reference |
---|---|---|
Lebanon | 3a (57%), 1a (21%), 4 (18%) | Mahfoud et al. [15] |
Greece | 3a (59%), 1 (23%) | Raptopoulou et al. [16] |
Croatia | 1b (61%), 3a (26%) | Vince et al. [17] |
Serbia | 1b (41.4%), 3a (27.6%) | Stamenkovic et al. [18] |
Italy | 1a (30%), 3a (40%), 1b (11%) | |
France | 1b (27%), 3a (21%), 1a (18%) | Payan et al. [21] |
Spain | 1a (42.8%), 3a (20.6%) | Alonso Alonso et al. [22]; |
Portugal | 1a (64.9%), 3a (71.6%) | Almeida Calado et al. [23] |